Edwards Lifesciences elects nine directors and approves employee stock plan increases
At its annual meeting on May 8, 2025, Edwards Lifesciences stockholders elected nine director nominees, approved an advisory vote on named executive officer compensation, and ratified PricewaterhouseCoopers LLP as auditor for fiscal 2025. Stockholders also approved increases to the share reserves of the company's U.S. and international employee stock purchase plans.
Key points
- U.S. ESPP share reserve increased by 4,200,000 shares; International ESPP increased by 1,460,000 shares
- Executive pay advisory vote approved: 412,893,480.47 for and 56,265,224.07 against
- PricewaterhouseCoopers LLP ratified as independent auditor for the year ending December 31, 2025: 447,661,338.99 for and 49,958,008.47 against
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.